446
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA tumor protein 53 target gene 1 promotes cervical cancer development via regulating microRNA-33a-5p to target forkhead box K2

, , , , , & show all
Pages 572-584 | Received 07 Jul 2021, Accepted 02 Jan 2022, Published online: 28 Jan 2022

References

  • Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018;7(10):5217–5236.
  • Bhatla N, Aoki D, Sharma DN, et al. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143(Suppl 2):22–36.
  • Fang J, Zhang H, Jin S. Epigenetics and cervical cancer: from pathogenesis to therapy. Tumour Biol. 2014;35(6):5083–5093.
  • Bernard L, Fearon D, McFaul S, et al. Role of primary care enrolment in advanced cervical cancer diagnosis: a population-based case-control study. Int J Gynecol Cancer. 2020;30(1):29–34.
  • Tsikouras P, Zervoudis S, Manav B, et al. Cervical cancer: screening, diagnosis and staging. J BUON. 2016;21(2):320–325.
  • Kontostathi G, Zoidakis J, Anagnou NP, et al. Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring. Expert Rev Proteomics. 2016;13(8):731–745.
  • Xu J, Bai J, Zhang X, et al. A comprehensive overview of lncRNA annotation resources. Brief Bioinform. 2017;18(2):236–249.
  • Shao M, Ma H, Wan X, et al. Survival analysis for long noncoding RNAs identifies TP53TG1 as an antioncogenic target for the breast cancer. J Cell Physiol. 2020;235(10):6574–6581.
  • Chen X, Gao Y, Li D, et al. LncRNA-TP53TG1 participated in the stress response under glucose deprivation in glioma. J Cell Biochem. 2017;118(12):4897–4904.
  • Zhang Y, Yang H, Du Y, et al. Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA-96. Cancer Sci. 2019;110(9):2760–2772.
  • Rottiers V, Naar AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012;13(4):239–250.
  • Talkowski K, Kiełbasiński K, Peszek W, et al. Salinomycin modulates the expression of mRNAs and miRNAs related to stemness in endometrial cancer. Curr Pharm Biotechnol. 2021;22(2):317–326.
  • Guan X, Gu S, Yuan M, et al. MicroRNA-33a-5p overexpression sensitizes triple-negative breast cancer to doxorubicin by inhibiting eIF5A2 and epithelial-mesenchymal transition. Oncol Lett. 2019;18(6):5986–5994.
  • Nestal de Moraes G, Carneiro L, Maia R, et al. FOXK2 transcription factor and its emerging roles in cancer. Cancers (Basel). 2019;11(3):393.
  • Zhang ZR, Yang N. MiR-33a-5p inhibits the growth and metastasis of melanoma cells by targeting SNAI2. Neoplasma. 2020;67(4):813–824.
  • Zhang Y, Xu M, Chen J, et al. Prognostic value of the FOXK family expression in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy. Onco Targets Ther. 2020;13:9185–9201.
  • Zhang W, Zhou Q, Wei Y, et al. The exosome-mediated PI3k/Akt/mTOR signaling pathway in cervical cancer. Int J Clin Exp Pathol. 2019;12(7):2474–2484.
  • Zhang C, Liu P, Huang J, et al. Circular RNA hsa_circ_0043280 inhibits cervical cancer tumor growth and metastasis via miR-203a-3p/PAQR3 axis. Cell Death Dis. 2021 Sep 29;12(10):888.
  • Li J, Guo R, Liu Q, et al. Circular RNA Circ-ITCH inhibits the malignant behaviors of cervical cancer by microRNA-93-5p/FOXK2 axis. Reprod Sci. 2020;27(3):860–868.
  • Liu M, Yu J, Wang D, et al. Epigenetically upregulated MicroRNA-602 is involved in a negative feedback loop with FOXK2 in esophageal squamous cell carcinoma. Mol Ther. 2019;27(10):1796–1809.
  • Lin MF, Yang Y-F, Peng Z-P, et al. FOXK2, regulated by miR-1271-5p, promotes cell growth and indicates unfavorable prognosis in hepatocellular carcinoma. Int J Biochem Cell Biol. 2017;88:155–161.
  • Wang L, Zhao Y, Wang Y, et al. The role of galectins in cervical cancer biology and progression. Biomed Res Int. 2018;2018:2175927.
  • Yuan J, Jiang -Y-Y, Mayakonda A, et al. Super-enhancers promote transcriptional dysregulation in nasopharyngeal carcinoma. Cancer Res. 2017;77(23):6614–6626.
  • Pan J, Fang S, Tian H, et al. lncRNA JPX/miR-33a-5p/Twist1 axis regulates tumorigenesis and metastasis of lung cancer by activating Wnt/beta-catenin signaling. Mol Cancer. 2020;19(1):9.
  • Lin C, Xiang Y, Sheng J, et al. Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis. J Physiol Biochem. 2020;76(3):469–481.
  • Dai Y, Wu Z, Lang C, et al. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-beta signaling. Theranostics. 2019;9(21):6063–6079.
  • Kong J, Zhang Q, Liang X, et al. FOXK2 downregulation suppresses EMT in hepatocellular carcinoma. Open Med (Wars). 2020;15(1):702–708.
  • Du F, Qiao C, Li X, et al. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR. Theranostics. 2019;9(13):3879–3902.
  • Nestal de Moraes G, Khongkow P, Gong C, et al. Forkhead box K2 modulates epirubicin and paclitaxel sensitivity through FOXO3a in breast cancer. Oncogenesis. 2015;4(9):e167.
  • Jia Z, Wan F, Zhu Y, et al. Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma. Oncol Lett. 2018;15(6):8669–8680.
  • Li YJ, Wang Y, Wang YY. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway. J Cell Physiol. 2019;234(6):9577–9591.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.